Drug Shortage Report for TIMOLOL MALEATE-EX
Report ID | 94633 |
Drug Identification Number | 02242275 |
Brand name | TIMOLOL MALEATE-EX |
Common or Proper name | TIMOLOL |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | TIMOLOL |
Strength(s) | 0.25% |
Dosage form(s) | SOLUTION (EXTENDED RELEASE) |
Route of administration | OPHTHALMIC |
Packaging size | 5ml |
ATC code | S01ED |
ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2019-09-02 |
Estimated end date | 2021-09-17 |
Actual end date | 2021-09-13 |
Shortage status | Resolved |
Updated date | 2021-09-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.